Interstitial lung disease is a ?catch all? term for over 100 lung
diseases, including pulmonary fibrosis. (So, if you see someone below
listed as an interstitial lung disease specialist, this will include
I have listed top rated hospitals with the best medical staff in the
US. I have listed hospitals rather than just pulmonologists. When
you?re being seen at a top notch hospital, you not only get the
services of excellent doctors, but excellent facilities, staff, and
services too. These hospitals boast not only cutting edge technology
but perform research on lung diseases. You are far more likely to get
the best doctors and treatment at larger specialty medical centers.
National Jewish Center
Rated the top in the US for pulmonary diseases.
1400 Jackson Street
Denver, CO 80206
Main hospital phone number: (303) 388-4461
Dr. Kevin Brown
Director, Clinical Interstitial Lung Disease Program, National Jewish Medical
and Research Center, Assistant Professor of Medicine, University of Colorado
Health Sciences Center, Denver, Colorado
National Jewish Center has long been recognized as being a leader in
treating and diagnosing lung disorders.
Patients or Potential Patients
Contact our LUNG LINE directly at 1-800-222-LUNG (5864)
Weekdays: 10:00 am - 6:30 pm Eastern time or via LUNG LINE e-mail
Send an e-mail
?National Jewish Medical and Research Center has been named the best
respiratory hospital in the United States for the eighth straight
year, according to the magazine.
"It relies largely on what other pulmonologists think of us. We're
really thrilled that they regard us so highly," said William
Allstetter, National Jewish spokesman. "One of the things we do ...
that's different is the time our physicians take with the patients.
... An initial standard consultation lasts an hour and a half."
The Cleveland Clinic
9500 Euclid Avenue
Cleveland, OH 44195
?U.S.News & World Report Ranks Cleveland Clinic Department of
Pulmonary, Allergy & Critical Care Medicine One of Best Pulmonary
Hospitals in the Nation.
With the new rankings, The Department of Pulmonary, Allergy & Critical
Care Medicine received great news?a national ranking of 11 for
pulmonary care of respiratory disorders. The department, staffed by
some of the best doctors in the country in the fields of pulmonology,
critical care and allergies, attracts patients from all around the
globe who are seeking diagnosis or treatment for rare and complex
Located in the superbly-equipped Crile Building, the staff at the
Cleveland Clinic is proud of the research and treatment facilities
offered to patients and research physicians here, as well as the
excellent pulmonic treatment that earned the department a rank as one
of the best pulmonary hospitals in the United States.?
?How satisfied are outpatients with their care?
According to American Medical Group Association data, 97% of patients
treated in the Department of Pulmonary Medicine said they were
satisfied with their overall visit.
Would patients treated at this hospital recommend it to their families and friends?
98% of patients treated in the Department of Pulmonary Medicine said
they would recommend The Cleveland Clinic to their families and
?About the Department
Pulmonologists, critical care specialists and allergists in the
Department of Pulmonary, Allergy and Critical Care Medicine have
unparalleled expertise in the diagnosis and treatment of all diseases
encompassed by their specialty. This expertise and experience attracts
patients from all over the world who seek a definitive diagnosis or
state-of-the-art treatment, often for a rare or complex disorder.?
200 First Street,
Rochester, MN 55905-0001
(The Mayo Clinic sites would not load this evening ? perhaps they are
down for backups or updating. Here are the links anyway, as they will
surely be up soon)
"Andrew Limper, M.D., is a Mayo Clinic pulmonologist and principal
investigator of the clinical trial currently investigating
implications of the animal studies for human patients. "It is truly
exciting to see how rapidly these cellular studies were first shown
effective in mice, and we now are testing the agent in patients with
lung fibrosis," says Dr. Limper. "This offers a potential rational
approach to the treatment of this devastating disorder."
The Mayo researchers studied the biochemical chain of events and
communication between cells that transform healthy tissues into
uncontrolled fiber-producing growth that eventually blocks lung
function and leads to death.
The hallmark of idiopathic fibrosis is the attraction to the lung of
abnormal cell types known as fibroblasts. When fibroblasts are acted
on by the growth factor TGF-Beta, they transform into spindle-shaped
cells known as myofibroblasts. Scientists believe these cells do the
real damage to tissue that leads to lung failure. Because TGF-Beta
stimulates c-Abl, the researchers decided to test a known c-Abl
inhibitor Gleevec for its ability to slow or stop the transformation
of fibroblasts into myofibroblasts. They found that Gleevec inhibited
Durham, NC 27710
Dr. David Schwartz
Professor of Medicine and Genetics, Chief, Division of Pulmonary and
Critical Care Medicine
Duke University Medical Center, Durham, North Carolina
To make an appointment with a Duke pulmonologist, call 1-888-ASK-DUKE.
RODNEY J. FOLZ, MD, PhD
Pulmonary, Allergy and Critical Care
DUMC 2620, Durham, NC 27710
Asthma, emphysema, COPD, chronic bronchitis, pulmonary complications
of bone marrow transplants, drug-induced lung disease, lung fibrosis,
interstitial lung disease, sarcoid, lung mass
?At Duke, we have physicians who specialize in the diagnosis and
treatment of advanced lung diseases such as IPF. We see over 200 new
referals a year for ILD. More importantly, we have the expertise of a
team of expert radiologists, pathologists, and surgeons who often aide
our efforts in providing more accurate diagnoses. In addition, we have
several important clinical and basic science studies investigating the
pathogenesis, genetics, and treament of various ILD's, specifically
with respect to IPF. Specifically, we have established a human lung
tissue repository obtained from patients with ILD, we are studying the
genetic determinants of Familial Interstitial Pneumonia having the
worlds largest collection of families with inheritied forms of
interstitial pneumonia, we are collaborating with the Duke Clinical
Research Institute (DCRI) which serves as the Datat Coordinating
Center for the NIH-sponsored IPF Clinical Research Network, and we are
participating in multi-centered clinical trials in the treatment of
IPF. Moreover, our lung transplantation program has provided even more
insight into the care of patients with advanced ILD's.?
?The winners of the 2005 Most Wired award were chosen upon review of
502 surveys, representing 1,255 hospitals across the country. Results
from the survey were used to measure the nation's hospitals on their
use of information technology in five areas: quality, customer
service, public health and safety, business processes and workforce
"There are three key differences in how hospitals apply and use
information technology to improve care," said Alden Solovy, executive
editor of Hospitals & Health Networks, the journal of the American
Hospital Association (AHA). "The Most Wired use a wider array of IT
tools to address quality and safety, they have a significantly larger
percentage of physicians who enter orders themselves and they conduct
a larger percentage of clinical activities via information
Duke has been investing in and integrating a large amount of clinical
technology into the health system, especially over the last two years,
said Asif Ahmad, vice president and chief information officer of Duke
Health Technology Solutions. "It's an honor to be recognized among the
best of the best for the use of technology to provide better care and
to integrate our hospitals into a better system."
Along with the list of the 2005 Most Wired winners, Hospital & Health
Networks released the results of an analysis showing that those
hospitals and health systems that have made a substantial investment
in health information technology have lower mortality rates than other
A bonus of selecting Duke will be the abundance of delicious North
Carolina barbeque and melt-in-your-mouth biscuits in the local
restaurants. Durham also is a smaller town and easier to navigate. The
university campus is beautiful to walk through and there are always
concerts and lectures to attend. (I worked at he Medical Center for
Robert Strieter, M.D.
Dept of Med, Pathol & Lab Med
UCLA Sch of Med - Box 711922
900 Veteran Ave 14-154 Warren Hall
Los Angeles, CA 90024-1922
Pulmonary and Critical Care Medicine: (310) 825-8061 Information and referral
?This is the first study of its kind, and researchers note that
pulmonary fibrosis and coronary artery disease may prove very similar
? both cause inflammation that leads to scarring and/or plaque
development. "Visually the disease processes look very much the same,"
Zisman said. According to Zisman, this study adds to the growing body
of research taking a closer look at the impact of the inflammation
process throughout the body. "Inflammation plays a key role in so many
diseases, from Alzheimer's disease and heart disease to cancers as
well as pulmonary fibrosis," Zisman said. "The more we learn about the
interaction of such diseases, the better we will be able to direct
treatments." "In the next step of research, we will look more closely
at the processes that underlie development of these two diseases,"
said Dr. Robert M. Strieter, a study author, chief of the Division of
Pulmonary and Critical Care Medicine, and vice chair of medicine at
the David Geffen School of Medicine at UCLA. He adds that the disease
process generating pulmonary fibrosis in the lungs may have more
systemic effects ? causing similar inflammation processes in other
areas of the body, such as development of coronary artery disease.?
The University of Washington State
UW Medical Center Operator
Call 1-800-852-8546 to schedule an appointment.
Here you will find not one, but a host of world renown pulmonologists
?The Chest Clinic at UW Medical Center provides complete specialty
care to patients with breathing problems. We are internationally known
for the management of interstitial lung disease (ILD), pulmonary
fibrosis, sarcoidosis, emphysema, pulmonary hypertension, cystic
fibrosis, and lung transplant-related problems.
The Chest Clinic also specializes in treating rare lung conditions
such as lymphangioleomytosis, histiocytosis-X, inherited interstitial
lung disease and familial pulmonary fibrosis. We also treat
neuromuscular diseases affecting lung function, asthma, and sleep
apnea. We can arrange non-invasive ventilation support for patients
with muscular dystrophy and other neuromuscular problems, if
This page had lots of information links:
If any part of this answer is unclear, please request an Answer
Clarification before rating. This will enable me to assist you
further, if possible.
I wish you and your father-in-law the best!
Interstitial lung disease + specialists
Top rated pulmonologists